BHVN - biohavenpharma.com Income before deduction of interest, taxes and amortization
Demand for neurological drugs remains stable regardless of market cycles, rendering the business defensive. Absolute operating income before depreciation and amortization demonstrates current cash efficiency, where 0.00 determines this parameter level. Biohaven Ltd. (BHVN) successfully competes with tech giants through patent protection of small molecules, while future data on ALS therapy will serve as key growth catalysts.
Summary analytical data breakdowns for Biohaven (BHVN)
- market value and analyst target forecast:
- market capitalization statistics:
- book capitalization information:
- business debt structure and liquidity details:
- business earnings and investment ratios data:
BHVN - Net Profit|Net Profit Forecast Biohaven Ltd.|BHVN - Price to Earnings Ratio|Market Cap to Projected Earnings biohavenpharma.com|BHVN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biohaven|BHVN - Operating profit EBITDA|Earnings per share for the trailing year Biohaven|BHVN - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months biohavenpharma.com|BHVN - Earnings per share growth in current year|Projected earnings per share growth rate for next year Biohaven Ltd.
Fundamental company valuation:Biohaven Corp
Assessing the asset quality of Biohaven Ltd. (BHVN) requires an analysis of actual cash generation. By analyzing the absolute EBITDA volume, an investor observes operating profit before depreciation and interest, reflecting the net efficiency of the core business. This metric allows for the exclusion of accounting adjustments to evaluate the actual cash inflow. Amid geopolitical instability and logistical barriers, this indicator demonstrates the resilience of drug sales. Steady growth in this figure confirms the preservation of the issuer's capital.
Competitors of Biohaven Ltd. (BHVN)
Biogen Idec (BIIB) - Profit before interest, taxes and amortization|Neurocrine Biosciences - Operating profit EBITDA|Income before deduction of interest, taxes and amortization RGC (regencellbioscience.com)|AXSM: Operating profit EBITDA|ACADIA Pharma (ACAD) - Operating profit EBITDA|Operating profit before deduction of amortization XENE|Profit before payment of interest, taxes and amortization VKTX|Operating profit EBITDA SUPN|CPRX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY: Operating profit before amortization|AMLX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TRVI (Trevi Corp)|Praxis Precision Medicines (PRAX) - Profit before payment of interest, taxes and amortization|AVXL (anavex.com) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization CBLL|PRTA (Prothena Corporation PLC) - Company profit before taxes, interest and amortization|Operating profit EBITDA ALEC|Annexon Biosciences Inc. - Operating profit before amortization|Omeros - Operating profit before deduction of amortization|Operating income before deduction of amortization neurogene.com (NGNE)|AC Immune SA - Operating profit EBITDA|VYGR: Profit before payment of interest, taxes and amortization|NMRA: Operating profit EBITDA|Scilex Holding Company, Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization TVGN|Profit before payment of interest, taxes and amortization ACOG|Profit before payment of interest, taxes and amortization Cognition Therapeutics, Inc. (CGTX)|Inhibikase Therapeutics Inc - Operating profit before amortization|Profit before payment of interest, taxes and amortization Cassava SAVA|ASRT: Operating profit before amortization|Coya - Operating profit EBITDA|Profit before interest, taxes and amortization Vistagen Therapeutics|OVID (ovidrx.com) - Operating profit before deduction of amortization|Acumen Pharmaceuticals Inc. (ABOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CervoMed Inc|ATHE: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|PEPG - Profit before interest, taxes and amortization|Operating profit EBITDA JUNS (Jupiter Neurosciences)|Relmada Therapeutics Inc - Profit before payment of interest, taxes and amortization|Annovis Bio Corp - Operating profit EBITDA|Operating income before deduction of amortization Grace Therapeutics, Inc. GRCE|Firefly Neuroscience, Inc (AIFF) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|NRSN (NeuroSense Therapeutics Ltd) - Operating profit EBITDA|RVPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MTVA|Operating profit EBITDA NeurAxis Inc (NRXS)|Helius Medical Technologies - Operating profit before deduction of amortization|Passage Bio Inc. - Profit before payment of interest, taxes and amortization|Neuphoria - Operating profit EBITDA|Profit before interest, taxes and amortization Minerva Neurosciences Inc|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ADXN|Operating profit before deduction of amortization ALZN|CYCN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Profit before payment of interest, taxes and amortization KTTA (pasitheaclinics.com)|Cortigent - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ATXI (Avenue Therapeutics Inc)|Brainstorm Cell - Operating profit EBITDA|CARA (caratherapeutics.com) - Operating profit before amortization|CHRO (Chromocell Therapeutics Corp.) - Operating profit before deduction of amortization|ELYM - Operating income before deduction of amortization|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization LBPH|Operating profit EBITDA MRNS|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Sage Therapeutics Inc. - Profit before payment of interest, taxes and amortization|SNPX - Profit before payment of interest, taxes and amortization|TRVN (Trevena Inc) - Operating profit before amortization|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WENA|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
